CD20 mimicry by a mAb rituximab-specific linear peptide: A potential tool for active immunotherapy of autoimmune diseases

Annals of the New York Academy of Sciences

Volumn 1051, Issue , 2005, Pages 672-683

  Perosa, Federico ^a   Favoino, Elvira ^a   Caragnano, Maria Antonietta ^a   Dammacco, Franco ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

Author keywords

Autoimmune disease; CD20 antigen; Immunotherapy; Mimotopes; Molecular mimicry; Peptide, vaccine

Indexed keywords

CD20 ANTIGEN; FREUND ADJUVANT; HLA ANTIGEN CLASS 1; INFLIXIMAB; KEYHOLE LIMPET HEMOCYANIN; PEPTIDE LIBRARY; RITUXIMAB; SYNTHETIC PEPTIDE;

ACTIVE IMMUNIZATION; AMINO ACID SEQUENCE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOCHEMISTRY; MOLECULAR MIMICRY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHAGE DISPLAY; PROTEIN MOTIF; RAJI CELL; T LYMPHOCYTE;

EID: 25444465900     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1361.112     Document Type: Conference Paper

References (31)

1. COIFFIER, B. 2004. New treatment strategies in lymphomas: aggressive lymphomas. Ann. Hematol. 83: S73-S74.
2. HENNESSY, B.T., E.O. HANRAHAN & P.A. DALY. 2004. Non-Hodgkin lymphoma: an update. Lancet Oncol. 5: 341-353.
3. DI GAETANO, N., E. CITTERA, R. NOTA, et al. 2003. Complement activation determines the therapeutic activity of rituximab in vivo. J. Immunol. 171: 1581-1587.
4. LIPSKY, P.E. 2001. Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity. Nat. Immunol. 2: 764-766.
5. LOONEY, R.J. 2002. Treating human autoimmune disease by depleting B cells. Ann. Rheum. Dis. 61: 863-866.
6. KNEITZ, C., M. WILHELM & H.P. TONY. 2002. Effective B cell depletion with rituximab in the treatment of autoimmune diseases. Immunobiology 206: 519-527.
7. LEANDRO, M.J., J.C. EDWARDS, G. CAMBRIDGE, et al. 2002. An open study of B lymphocyte depletion in systemic lupus erythematosus. Arthritis Rheum. 46: 2673-2677.
8. WAKIM, M., A. SHAH, P.A. ARNDT, et al. 2004. Successful anti-CD20 monoclonal antibody treatment of severe autoimmune hemolytic anemia due to warm reactive IgM autoantibody in a child with common variable immunodeficiency. Am. J. Hematol. 76: 152-155.
9. EDWARDS, J.C., L. SZCZEPANSKI, J. SZECHINSKI, et al. 2004. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N. Engl. J. Med. 350: 2572-2581.
10. D'ARCY, C.A. & M. MANNIK. 2001. Serum sickness secondary to treatment with the murine-human chimeric antibody IDEC-C2B8 (rituximab). Arthritis Rheum. 44: 1717-1718.
11. HERISHANU, Y. 2002. Rituximab-induced serum sickness. Am. J. Hematol. 70: 329.
12. ROBERTS, W.K., P.O. LIVINGSTON, D.B. AGUS, et al. 2002. Vaccination with CD20 peptides induces a biologically active, specific immune response in mice. Blood 99: 3748-3755.
13. UCHIDA, J., Y. HAMAGUCHI, J.A. OLIVER, et al. 2004. The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy. J. Exp. Med. 199: 1659-1669.
14. DESAI, S.A., X. WANG, E.J. NORONHA, et al. 2000. Structural relatedness of distinct determinants recognized by monoclonal antibody TP25.99 on beta 2-microglobulin-associated and beta 2-microglobulin-free HLA class I heavy chains. J. Immunol. 165: 3275-3283.
15. CARRERA, A.C., F. SANCHEZ-MADRID, M. LOPEZ-BOTET, et al. 1987. Involvement of the CD4 molecule in a post-activation event on T cell proliferation. Eur. J. Immunol. 17: 179-186.
16. PEROSA, F., G. LUCCARELLI, M. PRETE, et al. 2003. Beta 2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide. J. Immunol. 171: 1918-1926.
17. PEROSA, F., R. CARBONE, S. FERRONE, et al. 1990. Purification of human immunoglobulins by sequential precipitation with caprylic acid and ammonium sulphate. J. Immunol. Methods 128: 9-16.
18. LAEMMLI, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
19. STREICHER, H.Z., F. CUTTITTA, G.K. BUCKENMEYER, et al. 1986. Mapping the idiotopes of a monoclonal anti-myoglobin antibody with syngeneic monoclonal anti-idiotypic antibodies: detection of a common idiotope. J. Immunol. 136: 1007-1014.
20. PEROSA, F., S. FERRONE & F. DAMMACCO. 1991. Anti-idiotypic monoclonal antibodies reacting with idiotope on isolated-denatured chains of an anti-CD4 monoclonal antibody. Immunology 74: 748-750.
21. POLYAK, M.J. & J.P. DEANS. 2002. Alanine-170 and proline-172 are critical determinants for extracellular CD20 epitopes; heterogeneity in the fine specificity of CD20 monoclonal antibodies is defined by additional requirements imposed by both amino acid sequence and quaternary structure. Blood 99: 3256-3262.
22. MORELAND, L.W., E.E. MORGAN, T.C. ADAMSON III, et al. 1998. T cell receptor peptide vaccination in rheumatoid arthritis: a placebo-controlled trial using a combination of Vbeta3, Vbeta14, and Vbeta17 peptides. Arthritis Rheum. 41: 1919-1929.
23. ST. CLAIR, E.W., S.B. COHEN, M.L. LEE, et al. 2000. Treatment of rheumatoid arthritis with a DR4/1 peptide. J. Rheumatol. 27: 1855-1863.
24. PEROSA, P., G. LUCCARELLI, M. SCUDELETTI, et al. 2002. Assessment of safety and the immune response to the CD4 "internal antigen" mouse anti-idiotypic Mab 16D7 in four patients with SLE. J. Clin. Immunol. 22: 13-22.
25. BYNOE, M.S., J.T. EVANS, C. VIRET, et al. 2003. Epicutaneous immunization with autoantigenic peptides induces T suppressor cells that prevent experimental allergic encephalomyelitis. Immunity 19: 317-328.
26. RIEMER, A.B., M. KLINGER, S. WAGNER, et al. 2004. Generation of peptide mimics of the epitope recognized by trastuzumab on the oncogenic protein Her-2/neu. J. Immunol. 173: 394-401.
27. VAN REGENMORTEL, M.H. 2002. Reductionism and the search for structure-function relationships in antibody molecules. J. Mol. Recognit. 15: 240-247.
28. WESTERINK, M.A., P.C. GIARDINA, M.A. APICELLA, et al. 1995. Peptide mimicry of the meningococcal group C capsular polysaccharide. Proc. Natl. Acad. Sci. USA 92: 4021-4025.
29. KIEBER-EMMONS, T., P. LUO, J. QIU, et al. 1999. Vaccination with carbohydrate peptide mimotopes promotes anti-tumor responses. Nat. Biotechnol. 17: 660-665.
30. VALADON, P, G. NUSSBAUM, L.F. BOYD, et al. 1996. Peptide libraries define the fine specificity of anti-polysaccharide antibodies to Cryptococcus neoformans. J. Mol. Biol. 261: 11-22.
31. OLDENBURG, K.R., D. LOGANATHAN, I.J. GOLDSTEIN, et al. 1992. Peptide ligands for a sugar-binding protein isolated from a random peptide library. Proc. Natl. Acad. Sci. USA 89: 5393-5397.